Taken together, these results, along with the conclusion of our multi-cancer clinomic approach, provide a tantalizing list of lncRNA targets that are regulated by GATA4 and 6, exhibit cancer-specific patterns of expression even among related GI cancers, and constitute metagene signatures with elevated diagnostic and prognostic potency for GC. The gene discussed is GATA4; the disease is cancer.